Exposure–response relationships for the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin with regard to renal risk markers

AIMS: To quantitate the consistency of an individual's plasma exposure to dapagliflozin upon re‐exposure, and to investigate whether the individual's systemic exposure to dapagliflozin explains inter‐individual variation in response to dapagliflozin with regard to multiple renal risk marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Kroonen, Marjolein Y. A. M., Koomen, Jeroen V., Petrykiv, Sergei I., Laverman, Gozewijn D., Heerspink, Hiddo J. L., Stevens, Jasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318259/
https://www.ncbi.nlm.nih.gov/pubmed/31984620
http://dx.doi.org/10.1111/dom.13976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318259/
https://www.ncbi.nlm.nih.gov/pubmed/31984620
http://dx.doi.org/10.1111/dom.13976

Ejemplares similares